Clinical Trial Update: Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)

View source ↗

Summary

The clinical trial investigates long-term outcomes of dupilumab (DUPIXENT) in adults with chronic rhinosinusitis with nasal polyps; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Chronic Rhinosinusitis With Nasal Polyposis | Status: ACTIVE_NOT_RECRUITING